INS and Insulin resistance: In agreement with our results, Karen L.Teff et al[10] reported that olanzapine causes significant elevations in postprandial insulin, glucagon-like peptide 1, and glucagon coincident with insulin resistance in the absence of weight gain in healthy subjects.